Drug discovery crystal ball gazing for the year ahead. And the hottest new prospects are discussed below. We have 1 CDER (FDA) approval this year, an interesting start – Zelsuvmi (berdazimer), a nitric oxide (NO) releasing agent for the treatment of molluscum contagiosum. Berdazimer is a polymeric ...

Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition ...

The U.S. Food and Drug Administration on Friday approved Pfizer Inc’s nasal spray for migraine, giving patients access to a potentially fast-acting option to treat their headaches. The drug Zavzpret, also known as zavegepant, was approved for the treatment of acute migraine with or without aura ...

Pfizer Inc agreed to extend its COVID-19 vaccine contract from 2023 to 2026 with the European Union, the Financial Times reported on Tuesday, citing people with knowledge of the matter. The drugmaker has offered to cut the number of doses being supplied by 40 per cent and delay delivery of the shots, ...